Evidence map›Paper›PMID 42466597›Full record

ArticleMicrobiology and immunology2026

Identification of Two Competition-Defined Neutralizing Antibody Groups Targeting the HHV-6B gH/gL/gQ1/gQ2 Complex Independent of CD134 Binding.

Achmad Januar Er Putra, Ida Ayu Gde Wahyudevi Dharmika, Natsumi Hasegawa, Regina Rachel Gunawan, Rei Takamiya, Mitsuhiro Nishimura, Yasuko Mori

Abstract read
In one paragraph

Article in Microbiology and immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Achmad Januar Er PutraDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Ida Ayu Gde Wahyudevi DharmikaDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Natsumi HasegawaDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Regina Rachel GunawanDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Rei TakamiyaDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Mitsuhiro NishimuraDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Yasuko MoriDivision of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.ORCID https://orcid.org/0000-0002-6595-8522

Funding

JSPS KAKENHI JP24K02287 (YM)JSPS KAKENHI JP25K09529 (MN)Ministry of Education, Culture, Science, Sports and Technology of Japan (MEXT) research fellowship
6 · The paper itself

Abstract

Human herpesvirus 6B (HHV-6B) entry is mediated by the interaction between gH/gL/gQ1/gQ2 complex (tetramer) and CD134 expressed on activated T cells. In this study, we identified and characterized a panel of monoclonal antibodies targeting the HHV-6B tetramer, with particular focus on three antibodies; gHgL J1, gHgL O2, and gHgL F5; that represent anti-gH neutralizing monoclonal antibodies with binding characteristics distinct from the previously described antibody OHV-3. Immunofluorescence and Western blot analyses confirmed recognition of the HHV-6B tetramer in infected and transfected cells. Biolayer interferometry (BLI) demonstrated that these antibodies exhibited dissociation constants (K

Indexed as

Antibodies, NeutralizingAntibodies, ViralHerpesvirus 6, HumanReceptors, OX40Viral Envelope ProteinsAntibodies, MonoclonalBinding, CompetitiveHumansProtein BindingVirus InternalizationAntibodies, MonoclonalAntibodies, NeutralizingAntibodies, ViralReceptors, OX40TNFRSF4 protein, humanViral Envelope Proteinsantigenic regionsbiolayer interferometryCD134gH/gL/gQ1/gQ2 glycoprotein complexHHV‐6Bmonoclonal antibodyneutralization

Identifiers

PMID42466597
PMCPMC13551653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.